Syed Muneeb Uddin

Syed Muneeb Uddin

Dow University of Health Sciences Karachi - Nakhon Pathom / Pakistan
Others
AD Scientific Index ID: 5748850
ڈاؤ یونیورسٹی آف ہیلتھ سائنسز کراچی
person_outline Syed Muneeb Uddin's MOST POPULAR ARTICLES
1-) Hyperimmune anti-COVID-19 IVIG (C-IVIG) treatment in severe and critical COVID-19 patients: A phase I/II randomized control trialS Ali, SM Uddin, E Shalim, MA Sayeed, F Anjum, F Saleem, ...EClinicalMedicine 36, 2021582021
2-) Production of hyperimmune anti-SARS-CoV-2 intravenous immunoglobulin from pooled COVID-19 convalescent plasmaS Ali, SM Uddin, A Ali, F Anjum, R Ali, E Shalim, M Khan, I Ahmed, ...Immunotherapy 13 (5), 397-407, 2021322021
3-) Hyperimmune anti-COVID-19 IVIG (C-IVIG) Therapy for Passive Immunization of Severe and Critically Ill COVID-19 Patients: A structured summary of a study protocol for a …S Ali, S Luxmi, F Anjum, SM Muhaymin, SM Uddin, A Ali, MR Ali, ...Trials 21, 1-3, 2020152020
4-) Hyperimmune anti-COVID-19 IVIG (C-IVIG) treatment in severe and critical COVID-19 patients: A phase I/II randomized control trial. EClinicalMedicine. 2021; 36: 100926S Ali, SM Uddin, E Shalim52021
5-) Phase II/III trial of hyperimmune anti-COVID-19 intravenous immunoglobulin (C-IVIG) therapy in severe COVID-19 patients: study protocol for a randomized controlled trialS Ali, E Shalim, F Farhan, F Anjum, A Ali, SM Uddin, F Shahab, M Haider, ...Trials 23 (1), 932, 202212022